Association of Intraoperative Haemodynamic and Postoperative Complications in Type A Aortic Dissection Surgery
1 other identifier
observational
543
1 country
1
Brief Summary
Background To determine whether venous congestion is an important predictor of postoperative kidney injury and other adverse events after type A aortic dissection (TAAD). Methods Authors collected data of adults who underwent surgery for TAAD between January 2016 and July 2023. Primary exposures were venous congestion defined by central venous pressure (CVP) and mean arterial pressure (MAP). The primary outcomes were acute kidney injury (AKI) and acute injury disease (AKD). The secondary outcomes encompassed death and stroke. Restricted cubic spline regression model was used to adjust for confounding factors and multiple comparisons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 6, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedJune 3, 2024
September 1, 2023
3 months
May 6, 2024
May 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Incidence of AKI
AKI diagnosis adhered to the Kidney Disease Improvement Global Prognosis Organization (KDIGO) criteria.
After the surgery,up to 7 days
The Incidence of AKD
AKD staging was determined based on the Acute Disease Quality Initiative (ADQI) Working Group consensus, using available Scr values from 8 to 90 days post-surgery.
After the surgery,longer than 7 days but within 90 days
Secondary Outcomes (5)
The days of stay in hospital
perioperatively
The days of stay in ICU
after surgery
The incidence of in-hospital mortality
after surgery
The incidence of 30-day all-cause mortality
after surgery
The incidence of stroke
after surgery
Interventions
After the induction of anaesthesia, a central venous or pulmonary artery catheter was positioned. Based on prior studies, thresholds for central venous pressure were set at 10, 12, 16, and 20 mm Hg. Venous congestion was quantified by time exceeding each CVP threshold and the area under the curve (AUC) surpassing each CVP threshold in mmHg × min. Assessments were limited to pre- and post-CPB periods, as the venous drainage cannulate generated negative CVP during CPB. An arterial catheter was installed upon room admission. Continuous arterial blood pressure monitoring commenced after exposure to atmospheric pressure and calibration to zero. The MAP was determined using the formula: 2/3 × diastolic blood pressure + 1/3 × systolic blood pressure. Data were logged by automated software every minute. Established thresholds for MAP were 55, 65, and 75 mm Hg. Hypotension was quantified as (1) time under each MAP threshold in minutes and (2) the AUC below each MAP threshold in mmHg × min.
Eligibility Criteria
Eligible patients underwent surgery for TAAD.
You may qualify if:
- \) Eligible patients were adults, aged 18 or older.
You may not qualify if:
- Lacking preoperative serum creatinine (Scr) values
- Insufficient hemodynamic or laboratory data
- Exhibiting a preoperative Scr level ≥133 μmol/L
- Patients with renal insufficiency before surgery
- Patients on preoperative dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing First Hospital
Nanjing, Jiangsu, 210000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ya-li Ge
The First Affiliated Hospital with Nanjing Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2024
First Posted
June 3, 2024
Study Start
October 1, 2023
Primary Completion
January 1, 2024
Study Completion
March 1, 2024
Last Updated
June 3, 2024
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share